https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Aging and recovery after resistance-exercise-induced muscle damage: current evidence and implications for future research https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:39101 Wed 11 May 2022 14:35:35 AEST ]]> C1q and mobility score in predicting sarcopenia in an Australian cohort of cancer surgery patients https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52162 Wed 04 Oct 2023 10:50:47 AEDT ]]> Addressing sarcopenia in an aging population https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55572 Tue 11 Jun 2024 11:22:53 AEST ]]> Research trends and hotspots of exercise for people with sarcopenic: A bibliometric analysis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55517 Tue 04 Jun 2024 21:01:14 AEST ]]> Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17788 Sat 24 Mar 2018 07:57:23 AEDT ]]> Effect of androgen deprivation therapy on muscle attenuation in men with prostate cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17874 Sat 24 Mar 2018 07:56:44 AEDT ]]> Combining sarcopenia and ASA status to inform emergency laparotomy outcomes: could it be that simple? https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53774 Mon 15 Jan 2024 10:10:45 AEDT ]]> Protein Intake and Physical Activity Levels as Determinants of Sarcopenia Risk in Community-Dwelling Older Adults https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55458 Mon 03 Jun 2024 08:51:54 AEST ]]> Sarcopenia ‘made simple’ and outcomes from emergency laparotomy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50742 0.5696; P < 0.001). Conclusion: Radiological sarcopenia (CT-assessed PM:L3) is a significant predictor of mortality in EL patients in Australia. The results of this study suggest that radiological sarcopenia is equivalent to established risk assessment tools. The more timely and easily accessible CT-assessed PM:L3 metric is potentially automatable and may have significant utility in clinical practice.]]> Fri 04 Aug 2023 08:25:43 AEST ]]>